Format

Send to

Choose Destination
BMC Microbiol. 2014 Dec 5;14:307. doi: 10.1186/s12866-014-0307-2.

Diversity of Mycobacterium tuberculosis and drug resistance in different provinces of Papua New Guinea.

Author information

1
Swiss Tropical and Public Health Institute, Basel, Switzerland. serej.ley@unibas.ch.
2
University of Basel, Basel, Switzerland. serej.ley@unibas.ch.
3
Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. serej.ley@unibas.ch.
4
Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. nuen09@gmail.com.
5
Goroka Provincial Hospital, Goroka, Papua New Guinea. Kilagi.Vanuga@oktedi.com.
6
Alotau Provincial Hospital, Alotau, Papua New Guinea. ruben.kamus@hotmail.com.
7
Queensland Mycobacterium Reference Laboratory, Pathology Queensland, Brisbane, Australia. Robyn.Carter@health.qld.gov.au.
8
Queensland Mycobacterium Reference Laboratory, Pathology Queensland, Brisbane, Australia. Chris.Coulter@health.qld.gov.au.
9
Queensland Mycobacterium Reference Laboratory, Pathology Queensland, Brisbane, Australia. Sushil.Pandey@health.qld.gov.au.
10
Swiss Tropical and Public Health Institute, Basel, Switzerland. julia.feldmann@unibas.ch.
11
University of Basel, Basel, Switzerland. julia.feldmann@unibas.ch.
12
Swiss Tropical and Public Health Institute, Basel, Switzerland. mballif@ispm.unibe.ch.
13
University of Basel, Basel, Switzerland. mballif@ispm.unibe.ch.
14
Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. peter.siba@pngimr.org.pg.
15
Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. suparatp@hotmail.com.
16
Swiss Tropical and Public Health Institute, Basel, Switzerland. sebastien.gagneux@unibas.ch.
17
University of Basel, Basel, Switzerland. sebastien.gagneux@unibas.ch.
18
Swiss Tropical and Public Health Institute, Basel, Switzerland. hans-peter.beck@unibas.ch.
19
University of Basel, Basel, Switzerland. hans-peter.beck@unibas.ch.

Abstract

BACKGROUND:

Papua New Guinea (PNG) is a high tuberculosis (TB) burden country of the WHO Western Pacific Region, but so far research on drug resistance (DR) and genotypes of Mycobacterium tuberculosis (M. tuberculosis) was only conducted in few provinces in the country. The aim of the present study was to obtain baseline data on the level of drug resistance and the genotypic diversity of circulating M. tuberculosis in additional provinces and to investigate the differences between three selected sites across PNG.

RESULTS:

Genotyping of 147 M. tuberculosis clinical isolates collected in Goroka, Eastern Highlands Province, in Alotau, Milne Bay Province and in Madang, Madang Province revealed three main lineages of M. tuberculosis: Lineage 4 (European-American lineage), Lineage 2 (East-Asian lineage) and Lineage 1 (Indo-Oceanic lineage). All three lineages were detected in all three sites, but the individual lineage compositions varied significantly between sites. In Madang Lineage 4 was the most prevalent lineage (76.6%), whereas in Goroka and Alotau Lineage 2 was dominating (60.5% and 84.4%, respectively) (p < 0.001). Overall, phenotypic drug susceptibility testing showed 10.8% resistance to at least one of the first-line drugs tested. Of all resistant strains (23/212) 30.4% were Streptomycin mono-resistant, 17.4% were Isoniazid mono-resistant and 13% were Rifampicin mono-resistant. Multi-drug resistant (MDR) TB was found in 2.8% of all tested cases (6/212). The highest amount of MDR TB was found in Alotau in Milne Bay Province (4.6%).

CONCLUSION:

A large number of drug resistant TB infections are present in the country and MDR TB has already been detected in all three surveyed regions of PNG, highlighting the importance of monitoring drug resistance and making it a high priority for the National Control Program. Due to the high prevalence of Lineage 2 in Milne Bay Province and given the frequent association of this lineage with drug resistance, monitoring of the latter should especially be scaled up in that province.

PMID:
25476850
PMCID:
PMC4264550
DOI:
10.1186/s12866-014-0307-2
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center